Editorji is a popular short video news and information platform based in India. It was founded in 2018 by Vikram Chandra, one of India’s leading journalists, and has risen to prominence in the digital news space in a relatively short span of time. The platform is primarily designed for mobile devices, with applications available for Android and iOS.

ABOUT US:

about us editorji

Latest Video News: Editorji provides the latest news video headlines, latest videos clip from India and the World. Get all breaking news videos on Entertainment, Business, Coronavirus, Elections, Politics and more.

Latest Video News, Breaking News, Bollywood, Political, Sports, Business News | Editorji

+91 11 4035 6666 / info@editorji.com
3rd floor, Plot B, Khasara no 360, Sultanpur, New Delhi, Delhi 110030
<a title="mail to us" href="mailto:info@editorji.com">Send Feedback</a>
<a title="Contact Us" href="mailto:info@editorji.com">Contact Us</a>

REACH US

Contact for any questions, suggestions, comments, feedback or advertisement on Editorji.com, we are always looking forward to hearing from you.

Contact Us for Feedback, Suggestions and Advertising 

Editorji content is better experienced in our app.

The vaccine will administered for free to girls between 9 and 14 years of age and reports suggest the government is stocking up 7 crore doses ahead of the campaign.

India to launch free cervical cancer vaccine drive this year: reports

The vaccine will administered for free to girls between 9 and 14 years of age and reports suggest the government is stocking up 7 crore doses ahead of the campaign.

The central government is gearing up to launch a human papillomavirus (HPV) vaccination drive this year, in the hope of reducing occurrence of cervical cancer in the country. The campaign will target girls between 9 and 14 years of age and will be carried out in three phases in the second quarter of the year, according to media reports.&nbsp;
The vaccine will administered for free and the government is stocking up 7 crore doses ahead of the campaign, reports suggest.
Cervical cancer is the second most common cancer among women in India, and fourth most common in the world.
<h3>What is human papillomavirus?</h3>
Human papillomavirus (HPV) is a is highly transmissible virus that infects skin or mucosal cells that spreads through sexual activity. According to the World Health Organisation, at least 13 of more than 100 known HPV genotypes can cause cancer of the cervix and are associated with other anogenital cancers and cancers of the head and neck.&nbsp;
The two most common "high-risk" strains of HPV cause approximately 70% of all cervical cancers, while the two "low-risk" genotypes cause genital warts, according to a WHO report.
Getting vaccinated against HPV helps prevent cancer in men and women.
<h3>How effective is the HPV vaccine?</h3>
The HPV vaccine protects against genital warts and most cases of cervical cancer, according to the Mayo Clinic. It protects against cancer of the vagina, vulva, penis or anus caused by HPV. The HPV vaccine also protects against mouth, throat, head and neck cancers caused by HPV.
<h3>Who Should Get HPV Vaccine?</h3>
The primary target group in most of the countries recommending HPV vaccination is teenage girls, aged 9-14, prior to the start of sexual activity. The WHO recommends vaccination of secondary targets such as boys and older females where feasible and affordable.&nbsp;
The vaccination schedule depends on the age of the recipient. WHO recommends a one or two-dose schedule for girls aged 9-14, a one or two-dose schedule for girls and women aged 15-20, two doses with a 6-month interval for women older than 21.
A minimum of 2 doses and when feasible 3-doses remain necessary for those known to be immunocompromised and/or HIV-infected.

Cancer Vaccine: The Serum Institute of India (SII) is all set to launch its indigenously-developed cervical cancer vaccine by the end of this year. 

Cancer Vaccine: India to launch first cervical cancer vaccine by year-end

The Serum Institute of India (SII) is all set to launch its indigenously-developed cervical cancer vaccine by the end of this year. 

Good news! India to launch cervical cancer vaccine by year-end

Cervical Cancer Vaccine : The Serum Institute of India (SII) is all set to launch its indigenously-developed cervical cancer vaccine by the end of this year.&nbsp;

Cancer Vaccine: After the Drugs Controller General of India's (DCGI) approval, the Serum Institute of India (SII) is all set to launch its indigenously-developed cervical cancer vaccine later this year.&nbsp;
According to SII, the Quadrivalent Human Papillomavirus vaccine (qHPV) to treat <a href="https://www.editorji.com/story/hpv-vaccination-could-help-eradicate-cervical-cancer-1561793932391" target="_blank">cervical cancer</a> in women will be affordable and accessible.&nbsp;
Cervical <a href="https://www.editorji.com/world-news/first-human-trial-of-cancer-killing-drug-conducted-all-you-need-to-know-1653466391508" target="_blank">cancer </a>in India ranks as the second-most frequent cancer among women between 15 and 44 years of age. The vaccine is based on VLP (virus-like particles), similar to the Hepatitis B vaccine and protects by generating antibodies against the HPV virus L1 protein.
The trials for the vaccine started in 2019 and thousands of participants in the age group of 9‐26 years were part of the trials across India. Phase three results showed a robust immune response in 100 per cent of the vaccine recipients with good safety records.&nbsp;
Also watch: <a href="https://www.editorji.com/lifestyle-news/health/researchers-develop-new-single-shot-vaccine-to-cure-aids-1655465889962">Researchers develop a new single-shot vaccine to cure AIDS&nbsp;</a>

cervical cancer vaccine

Categories